LPA1 Inhibition Induces Metastatic Dormancy In Mouse Models Of Breast Cancer

[News]

A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to a study published August 21 in the Journal of the National Cancer Institute. Metastasis is a main contributor to mortality in cancer patients...

More... (http://www.medicalnewstoday.com/releases/249222.php)